Montes Archimedes Acquisition Corp

Completed

Follow

Detailed Information

Information on this SPAC.

Sponsors: Patient Square Capital
IPO Size: $500M
Underwriters: Citigroup
Jefferies
Focus: Healthcare, Pharmaceuticals, Technology
SEC Filings: 1819263
Public Embarc Page: https://embarc.com/capital/spac/1819263/MAAC/montes-archimedes-acquisition
IPO Ticker: MAAC

SPAC Leadership

Information on the SPAC leadership.

Chief Executive Officer and DirectorJames C. Momtazee
Chief Financial OfficerMaria C. Walker
DirectorGeorge Barrett
DirectorStephen Oesterle
DirectorSteve Oesterle

Target Information

Information on the SPAC target for merger.

Company: Roivant Sciences
Presentation: Investor Presentation (SEC) on 2021-06-25
New Ticker: ROIV ROIVW
Description: Roivant Sciences is a biopharmaceutical and healthcare technology company. "Since its founding in 2014, Roivant has put over 40 medicines into development across a wide range of disease areas."